Martin A. Lehr is Chief Executive Officer of Context Therapeutics Inc.. Currently has a direct ownership of 159,701 shares of CNTX, which is worth approximately $178,865. The most recent transaction as insider was on Feb 21, 2023, when has been sold 5,823 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $4,891. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
0% 3M change
0% 12M change
Total Value Held $178,865

Martin A. Lehr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2023
BUY
Open market or private purchase
$4,891 $0.84 p/Share
5,823 Added 3.52%
159,701 Common Stock
Feb 13 2023
BUY
Open market or private purchase
$4,877 $0.87 p/Share
5,606 Added 3.52%
153,878 Common Stock
Feb 06 2023
BUY
Open market or private purchase
$4,888 $0.97 p/Share
5,040 Added 3.29%
148,272 Common Stock
Jan 30 2023
BUY
Open market or private purchase
$4,918 $0.7 p/Share
7,027 Added 4.68%
143,232 Common Stock
Jan 23 2023
BUY
Open market or private purchase
$4,924 $0.72 p/Share
6,839 Added 4.78%
136,205 Common Stock
Jan 17 2023
BUY
Open market or private purchase
$5,019 $0.74 p/Share
6,783 Added 4.98%
129,366 Common Stock
Dec 16 2022
BUY
Open market or private purchase
$14,800 $0.74 p/Share
20,000 Added 14.03%
122,583 Common Stock
Aug 19 2022
BUY
Open market or private purchase
$24,050 $1.85 p/Share
13,000 Added 11.25%
102,583 Common Stock
Oct 22 2021
BUY
Open market or private purchase
$50,000 $5.0 p/Share
10,000 Added 9.13%
99,583 Common Stock
MAL

Martin A. Lehr

Chief Executive Officer
Philadelphia, PA

Track Institutional and Insider Activities on CNTX

Follow Context Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTX shares.

Notify only if

Insider Trading

Get notified when an Context Therapeutics Inc. insider buys or sells CNTX shares.

Notify only if

News

Receive news related to Context Therapeutics Inc.

Track Activities on CNTX